Details for Patent: 5,231,095

✉ Email this page to a colleague

Summary for Patent: 5,231,095

Patent landscape, scope, and claims:

Title:	S-timolol hemihydrate
Abstract:	A novel compound and compositions containing S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole hemihydrate useful for administration to a patient particularly for topical administration as a pharmaceutical agent for treating known conditions and disorders treatable with timolol.
Inventor(s):	Peralampi; Markku (Kangasala, FI)
Assignee:	Leiras Oy (Turku, FI)
Application Number:	07/663,853
Patent Claim Types: see list of patent claims	Compound; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,231,095

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,231,095

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Finland	884838	Oct 20, 1988

PCT Information
PCT Filed	October 13, 1989	PCT Application Number:	PCT/FI89/00196
PCT Publication Date:	May 03, 1990	PCT Publication Number:	WO90/04592

International Family Members for US Patent 5,231,095

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	112277	⤷ Subscribe
Austria	154513	⤷ Subscribe
Australia	4329693	⤷ Subscribe
Australia	4347389	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.